- US12559531utility2026Claudin-6-specific Immunoreceptors and T Cell Epitopes0 cites
- US12390536utility2025Antibody-drug Complex Containing Toll-like Receptor 7/8 Dual Agonist Compound0 cites
- US12384794utility2025Quinazoline Compound for Inducing Degradation of G12D Mutant KRAS Protein0 cites
- US12209134utility2025Anti-human Fn14 Antibody0 cites
- US12202908utility2025Complex Having Anti-human MUC1 Antibody Fab Fragment, Peptide Linker And/or Ligand0 cites
- US12178814utility2024Pharmaceutical Composition0 cites
- US12161628utility2024Combination Therapy0 cites
- US12097189utility2024Pharmaceutical Composition for Modified Release0 cites
- US12065503utility2024Pharmaceutical Composition Containing Tagged Site-antihuman Antibody Fab Fragment Complex0 cites
- US12059409utility2024Pharmaceutical Composition for Modified Release0 cites
- US12036315utility2024Pharmaceutical Composition for Oral Administration Comprising Enzalutamide0 cites
- US12029797utility2024Fatty Acid Derivative Labeled with Positron-emitting Radionuclide0 cites
- US11944620utility2024Stable Pharmaceutical Composition for Oral Administration0 cites
- US11938130utility2024Stable Pharmaceutical Composition for Oral Administration0 cites
- US11938131utility2024Stable Pharmaceutical Composition for Oral Administration0 cites
- US11938132utility2024Stable Pharmaceutical Composition for Oral Administration0 cites
- US11938133utility2024Stable Pharmaceutical Composition for Oral Administration0 cites
- US11925638utility2024Pharmaceutical Composition Comprising Diamino Heterocyclic Carboxamide Compound as Active Ingredient0 cites
- US11707451utility2023Pharmaceutical Composition for Modified Release0 cites
Page 1 of 2Next →